Koyfin Home > Directory > Health Care > Adma Biologics > Cash and Short-Term Investments

Adma Biologics Cash and Short-Term Investments Chart (ADMA)

Adma Biologics annual/quarterly Cash and Short-Term Investments from 2010 to 2020.
  • Adma Biologics Cash and Short-Term Investments for the quarter ending June 06, 2020 was $76m a 36.65% increase of 28m year over year
  • Adma Biologics Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $76m a 36.65% increase of 28m year over year
  • Adma Biologics Annual Cash and Short-Term Investments for 2019 was $27m a 14.94% increase of 4m from 2018
  • Adma Biologics Annual Cash and Short-Term Investments for 2018 was $23m a -89.44% decrease of -20m from 2017
  • Adma Biologics Annual Cash and Short-Term Investments for 2017 was $43m a 64.50% increase of 28m from 2016
Other Balance Sheet Metrics:
  • Adma Biologics Total Assets for the quarter ending September 09, 2018 was $106m a -1.57% decrease of -2m year over year
  • Adma Biologics Other Liabilities for the quarter ending December 12, 2018 was $18m a -0.86% decrease of 0m year over year
  • Adma Biologics Total Equity for the quarter ending September 09, 2018 was $37m a -8.40% decrease of -3m year over year
View Chart On Koyfin

Quarterly ADMA Cash and Short-Term Investments Data

06/2020$76m
03/2020$101m
12/2019$27m
09/2019$48m
06/2019$74m
03/2019$17m
12/2018$23m
09/2018$42m
06/2018$55m
03/2018$26m

Annual ADMA Cash and Short-Term Investments Data

2019$27m
2018$23m
2017$43m
2016$15m
2015$17m
2014$22m
2013$29m
2012$13m
2011$0m
2010$0m